Saturday, May 31, 2025

Latest

MustGrow Biologics More Than Triples Financing To $6.9 Million Due To Demand

Demand within the natural biopesticide space from investors appears to be extremely strong. MustGrow Biologics (CSE: MGRO) this morning expanded its previously announced $2.0 million private placement rather significantly, with the offering now pegged at $6.9 million.

The financing will now see a total of roughly 2.7 million units sold, at a price of $2.60 per unit. Each unit contains one common share and one full warrant, with warrants valid for a period of two years and pegged at $4.00 per share.

Notably, Ira Gluskin and related parties have agreed to invest $1.0 million into the financing, under the same terms and conditions. Gluskin most notably is the co-founder of Gluskin Sheff + Associates, a major wealth management firm, while also serving as a director for a number of advisory committees.

The financing will see proceeds utilized for the development of its pipeline as well as for working capital and general corporate purposes.

The offering is currently slated to close October 6.

MustGrow Biologics last traded at $2.87 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

ESGold Begins Concentration Tests Ahead Of First Production

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

Related News

MustGrow Biologics: Three Things To Know

MustGrow Biologics (CSE: MGRO) has been on a high volume tear as of late, with...

Wednesday, February 19, 2020, 12:21:45 PM

Bayer, US Government Behind Thailand’s Glyphosate Ban Reversal

It appears that Bayer and the US government may have been undertaking some shady lobbying...

Sunday, September 20, 2020, 03:41:00 PM

MustGrow Sees Sumitomo Expand Development Program For Proprietary Tech

MustGrow Biologics (CSE: MGRO) has expanded its relationship with Japanese conglomerate Sumitomo Corporation. The firm...

Tuesday, December 14, 2021, 08:17:55 AM

MustGrow: Organic Disease Control – The Daily Dive

Today on the Daily Dive, we welcome back Colin Bletsky, COO and Director of MustGrow...

Monday, August 30, 2021, 01:30:00 PM

MustGrow Biologics Receives $1.5 Million From Exercise Of Warrants

MustGrow Biologics (CSE: MGRO) issued a brief news release this morning, indicating that it has...

Thursday, January 14, 2021, 07:57:13 AM